CRT NEXT Study Explained: 2‑Lead CRT‑DX vs. 3‑Lead CRT‑D | Interview with Dr. Mauro Biffi

14 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
A Shift in CRT Practice

How does 2‑lead CRT‑DX compare to conventional 3‑lead CRT‑D systems? In this exclusive BIOTRONIK interview, Dr. Mauro Biffi (Cardiology Department, IRCCS Sant’Orsola Malpighi Polyclinic) shares key insights from the CRT NEXT Study, where CRT‑DX was shown to be non‑inferior to conventional 3‑lead CRT‑D.

In this Q&A, Dr. Biffi discusses:

✔ The clinical rationale behind 2‑lead CRT‑DX systems

✔ Study design and key results of CRT NEXT

✔ What the results may mean for future CRT practice

✔ Key takeaways for electrophysiologists and cardiologists

This interview is part of BIOTRONIK’s commitment to advancing cardiac resynchronization therapy through innovation and clinical evidence.
Categoria
Cardiology
Commenta per primo questo video.

Prossimo